DE2300888A1 - Tabletten - Google Patents

Tabletten

Info

Publication number
DE2300888A1
DE2300888A1 DE2300888A DE2300888A DE2300888A1 DE 2300888 A1 DE2300888 A1 DE 2300888A1 DE 2300888 A DE2300888 A DE 2300888A DE 2300888 A DE2300888 A DE 2300888A DE 2300888 A1 DE2300888 A1 DE 2300888A1
Authority
DE
Germany
Prior art keywords
tablets
lower alkyl
amitriptyline
component
heated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2300888A
Other languages
German (de)
English (en)
Inventor
Prabhakar Ranchhordas Sheth
John James Vance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2300888A1 publication Critical patent/DE2300888A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2300888A 1972-01-10 1973-01-09 Tabletten Pending DE2300888A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21678072A 1972-01-10 1972-01-10

Publications (1)

Publication Number Publication Date
DE2300888A1 true DE2300888A1 (de) 1973-07-19

Family

ID=22808485

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2300888A Pending DE2300888A1 (de) 1972-01-10 1973-01-09 Tabletten

Country Status (7)

Country Link
US (1) US3792157A (fr)
AU (1) AU4986472A (fr)
BE (1) BE793775A (fr)
DE (1) DE2300888A1 (fr)
FR (1) FR2181660A1 (fr)
NL (1) NL7300356A (fr)
ZA (1) ZA728553B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2400360A1 (fr) * 1975-07-14 1979-03-16 Merck & Co Inc Comprimes a tons multiples et leur procede de preparation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104819A (en) * 1980-01-21 1981-08-20 Wellcome Found Blending agent
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2400360A1 (fr) * 1975-07-14 1979-03-16 Merck & Co Inc Comprimes a tons multiples et leur procede de preparation

Also Published As

Publication number Publication date
AU4986472A (en) 1974-06-13
US3792157A (en) 1974-02-12
FR2181660A1 (fr) 1973-12-07
ZA728553B (en) 1973-08-29
NL7300356A (fr) 1973-07-12
BE793775A (fr) 1973-07-09

Similar Documents

Publication Publication Date Title
DE69634053T2 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE1279896C2 (de) Die Verwendung eines sauren Copolymerisates zur Herstellung von Tabletten mit verlaengerter Wirkstoffabgabe
DE3441308C2 (de) Wirkstofffreie oder wirkstoffhaltige matrixbildende Granalien, geeignet zur Herstellung von pharmazeutischen Präparaten mit geregelter beziehungsweise verzögerter Wirkstoffabgabe sowie Verfahren zur Herstellung derselben
EP0128483B1 (fr) Formes galéniques d'antidiabétiques orales et procédé de leur préparation
DE69209080T2 (de) Pharmazeutische zusammemsetzungen mit verzoegerter freigabe
DE2530563A1 (de) Arzneimittelformulierungen mit geringem missbrauchpotential
DE3739690A1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3318649A1 (de) Zweiphasenformulierung
DE29522153U1 (de) Polymerbeschichtete Tablette umfassend Amoxycillin und Clavulanat
DE69218557T2 (de) Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69619979T2 (de) Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd
DE60203847T2 (de) Zusammensetzungen enthaltend S-Tofisopam sowie Verwendung dieser Zusammenset- zungen zur Herstellung eines Medikaments zur Behandlung oder Vorbeugung von Krämpfen oder Anfällen
DE2546577A1 (de) Neue galenische zubereitungen
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
DE10003757A1 (de) Ibuprofen-Wirkstoffzubereitung
DE69908421T2 (de) Pharmazeutische zusammensetzung enthaltend eine kombination der dextro- und laevo-isomeren von sotalol
DE19740983A1 (de) Verfahren zur Erschwerung der Extraktion von Wirkstoffen aus Tabletten
DE2300888A1 (de) Tabletten
DE69520292T2 (de) Pharmazeutische zubereitung zur direktverpressung
DE3417576A1 (de) Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung
DE3942131C2 (de) Pharmazeutisches Trimebutin-haltiges Präparat mit verlängerter Wirkstoff-Freisetzung und Verfahren zur Herstellung
EP0669826B1 (fr) Medicament contenant du (-)-metrifonate
EP0192098B1 (fr) Utilisation de 2-amino-6-allyl-5,6,7,8-tétrahydro-4H-thiazolo[4,5-d]azépine pour la production d'un médicament pour le traitement de la maladie de Parkinson, respectivement du parkinsonisme
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel